skip to main content
Idioma:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Busca Simples
Resultados 1 2 3 4 5 next page
Mostrar Somente
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Material Type:
Artigo 		Adicionar ao Meu Espaço

Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Haanen, J.B.A.G. ; Carbonnel, F. ; Robert, C. ; Kerr, K.M. ; Peters, S. ; Larkin, J. ; Jordan, K.

Annals of oncology, 2017-07, Vol.28 (suppl_4), p.iv119-iv142 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
2
Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Material Type:
Artigo 		Adicionar ao Meu Espaço

Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

Haanen, J. ; Obeid, M. ; Spain, L. ; Carbonnel, F. ; Wang, Y. ; Robert, C. ; Lyon, A.R. ; Wick, W. ; Kostine, M. ; Peters, S. ; Jordan, K. ; Larkin, J.

Annals of oncology, 2022-12, Vol.33 (12), p.1217-1238 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
3
Predicting response to cancer immunotherapy using noninvasive radiomic biomarkers
Predicting response to cancer immunotherapy using noninvasive radiomic biomarkers
Material Type:
Artigo 		Adicionar ao Meu Espaço

Predicting response to cancer immunotherapy using noninvasive radiomic biomarkers

Trebeschi, S. ; Drago, S.G. ; Birkbak, N.J. ; Kurilova, I. ; Cǎlin, A.M. ; Delli Pizzi, A. ; Lalezari, F. ; Lambregts, D.M.J. ; Rohaan, M.W. ; Parmar, C. ; Rozeman, E.A. ; Hartemink, K.J. ; Swanton, C. ; Haanen, J B A G ; Blank, C.U. ; Smit, E.F. ; Beets-Tan, R.G.H. ; Aerts, H.J.W.L

Annals of oncology, 2019-06, Vol.30 (6), p.998-1004 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
4
Autoimmune diseases and immune-checkpoint inhibitors for cancer therapy: review of the literature and personalized risk-based prevention strategy
Autoimmune diseases and immune-checkpoint inhibitors for cancer therapy: review of the literature and personalized risk-based prevention strategy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Autoimmune diseases and immune-checkpoint inhibitors for cancer therapy: review of the literature and personalized risk-based prevention strategy

Haanen, J. ; Ernstoff, M.S. ; Wang, Y. ; Menzies, A.M. ; Puzanov, I. ; Grivas, P. ; Larkin, J. ; Peters, S. ; Thompson, J.A. ; Obeid, M.

Annals of oncology, 2020-06, Vol.31 (6), p.724-744 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
5
Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study
Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study

Long, G.V. ; Flaherty, K.T. ; Stroyakovskiy, D. ; Gogas, H. ; Levchenko, E. ; de Braud, F. ; Larkin, J. ; Garbe, C. ; Jouary, T. ; Hauschild, A. ; Chiarion-Sileni, V. ; Lebbe, C. ; Mandalà, M. ; Millward, M. ; Arance, A. ; Bondarenko, I. ; Haanen, J.B.A.G. ; Hansson, J. ; Utikal, J. ; Ferraresi, V. ; Mohr, P. ; Probachai, V. ; Schadendorf, D. ; Nathan, P. ; Robert, C. ; Ribas, A. ; Davies, M.A. ; Lane, S.R. ; Legos, J.J. ; Mookerjee, B. ; Grob, J.-J.

Annals of oncology, 2017-07, Vol.28 (7), p.1631-1639 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
6
Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Material Type:
Artigo 		Adicionar ao Meu Espaço

Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Haanen, J B A G ; Carbonnel, F ; Robert, C ; Kerr, K M ; Peters, S ; Larkin, J ; Jordan, K

Annals of oncology, 2018-10, Vol.29 (Supplement_4), p.iv264-iv266 [Periódico revisado por pares]

England: Oxford University Press

Texto completo disponível

Citações Citado por
7
Starting the fight in the tumor: expert recommendations for the development of human intratumoral immunotherapy (HIT-IT)
Starting the fight in the tumor: expert recommendations for the development of human intratumoral immunotherapy (HIT-IT)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Starting the fight in the tumor: expert recommendations for the development of human intratumoral immunotherapy (HIT-IT)

Marabelle, A. ; Andtbacka, R. ; Harrington, K. ; Melero, I. ; Leidner, R. ; de Baere, T. ; Robert, C. ; Ascierto, P.A. ; Baurain, J -F ; Imperiale, M. ; Rahimian, S. ; Tersago, D. ; Klumper, E. ; Hendriks, M. ; Kumar, R. ; Stern, M. ; Öhrling, K. ; Massacesi, C. ; Tchakov, I. ; Tse, A. ; Douillard, J -Y ; Tabernero, J. ; Haanen, J. ; Brody, J.

Annals of oncology, 2018-11, Vol.29 (11), p.2163-2174 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
8
Discontinuation of anti-PD-1 antibody therapy in the absence of disease progression or treatment limiting toxicity: clinical outcomes in advanced melanoma
Discontinuation of anti-PD-1 antibody therapy in the absence of disease progression or treatment limiting toxicity: clinical outcomes in advanced melanoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Discontinuation of anti-PD-1 antibody therapy in the absence of disease progression or treatment limiting toxicity: clinical outcomes in advanced melanoma

Jansen, Y.J.L. ; Rozeman, E.A. ; Mason, R. ; Goldinger, S.M. ; Geukes Foppen, M.H. ; Hoejberg, L. ; Schmidt, H. ; van Thienen, J.V. ; Haanen, J.B.A.G. ; Tiainen, L. ; Svane, I.M. ; Mäkelä, S. ; Seremet, T. ; Arance, A. ; Dummer, R. ; Bastholt, L. ; Nyakas, M. ; Straume, O. ; Menzies, A.M. ; Long, G.V. ; Atkinson, V. ; Blank, C.U. ; Neyns, B.

Annals of oncology, 2019-07, Vol.30 (7), p.1154-1161 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
9
Efficacy and safety of ipilimumab in metastatic melanoma patients surviving more than 2 years following treatment in a phase III trial (MDX010-20)
Efficacy and safety of ipilimumab in metastatic melanoma patients surviving more than 2 years following treatment in a phase III trial (MDX010-20)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Efficacy and safety of ipilimumab in metastatic melanoma patients surviving more than 2 years following treatment in a phase III trial (MDX010-20)

McDermott, D. ; Haanen, J. ; Chen, T.-T. ; Lorigan, P. ; O'Day, S.

Annals of oncology, 2013-10, Vol.24 (10), p.2694-2698 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Citações Citado por
10
Tumor-infiltrating lymphocytes for the treatment of metastatic cancer
Tumor-infiltrating lymphocytes for the treatment of metastatic cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Tumor-infiltrating lymphocytes for the treatment of metastatic cancer

Geukes Foppen, M.H. ; Donia, M. ; Svane, I.M. ; Haanen, J.B.A.G.

Molecular oncology, 2015-12, Vol.9 (10), p.1918-1935 [Periódico revisado por pares]

United States: Elsevier B.V

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (254)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (270)
  2. Web Resources  (2)
  3. Book Chapters  (2)
  4. Reports  (1)
  5. Anais de Congresso  (1)
  6. Conjunto de Dados  (1)
  7. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1995  (11)
  2. 1995Até2004  (13)
  3. 2005Até2010  (34)
  4. 2011Até2017  (88)
  5. Após 2017  (132)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (267)
  2. Japonês  (16)
  3. Holandês  (6)
  4. Francês  (3)
  5. Russo  (1)
  6. Alemão  (1)
  7. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.